Liposomes for Targeted Delivery of Active Agents against Neurodegenerative Diseases (Alzheimer's Disease and Parkinson's Disease)

Neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease represent a huge unmet medical need. The prevalence of both diseases is increasing, but the efficacy of treatment is still very limited due to various factors including the blood brain barrier (BBB). Drug deliv...

Descripción completa

Detalles Bibliográficos
Autores principales: Spuch, Carlos, Navarro, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3238398/
https://www.ncbi.nlm.nih.gov/pubmed/22203906
http://dx.doi.org/10.1155/2011/469679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3238398/
https://www.ncbi.nlm.nih.gov/pubmed/22203906
http://dx.doi.org/10.1155/2011/469679

Ejemplares similares